A Blueprint for A Successful Capital Raising Using REG Offerings
DISRUPTION OF PRIVATE SECURITIES
The Democratization of Capital
Regulation A provides a vehicle for companies to raise up to $75 million per year from both accredited and non-accredited (“Main Street”) investors. This is made possible through the 2012 JOBS Act, which changed reporting and disclosure requirements for small and medium sized businesses.
Previously, they were restricted to either Venture Captial or onerous Regulation D offerings for growth capital. Regulation A provides capital-intensive life sciences companies with a viable alternative funding strategy. Read about the company that raised $60 million using Reg A+.
HOW WE HELP COMPANIES
CAPITAL PLANNING VALUATION STRATEGY™
Capital Planning Valuation Strategy™ (CPVS™) is our proprietary 6-week process designed to help business owners decide whether a Regulation A offering is right for them. CPVS™ provides a path to maintain control of your company through multiple cycles of fundraising while building a blueprint for a successful Regulation A Offering. Learn more about how a CPVS™ can help your business unlock growth capital today.
Learn More About CPVS™Client Testimonials
CPVS™ is the best capital raising analytics service on the market, and it’s the only one tailored specifically to healthcare companies like yours. But don’t just take our word for it…
“Medical Funding Professionals’ comprehensive approach to capital planning has been instrumental in shaping our fundraising strategy. The 1.5-hour presentation they delivered was particularly beneficial as it outlined several funding paths that could save us time and money compared to more conventional routes. Just as important, the strategies they proposed were tailored specifically to our funding needs and goals, resulting in a customized plan that exceeded our expectations.
We are now much better prepared to make capital raising decisions. I would recommend Medical Funding Professionals and their CPVS™ Process to any business owner or organization looking to raise capital.”
Curtis Rhine
CFO, RS BioTherapeutics
* [The above statement is provided from the client of the advisor. There has been no compensation paid of any type or kind in exchange for the statement. No material conflicts of interest exist arising from the relationship between the advisor and the client. The statements provided may not be indicative of all client experiences. There can be no performance guarantees or guarantees of success.]
“Since launching Manhattan Stret Capital in 2015, I’ve worked with hundreds of companies wanting to raise capital, and the fact of the matter is, most of them simply aren’t prepared—not that their business isn’t a good candidate for raising money, but they just aren’t ready in terms of founder knowledge, corporate organization, capitalization, presentation, and marketing.
That’s why I’m very impressed by what Stephen Brock has brought to the table. His Capital Planning Valuation Strategy™ is a systematic, progressive approach following the best practices of capital raising. He invests the time in educating them on corporate structure, the various types of fundraising opportunities and what’s appropriate for them. Understanding securities is complex, and Stephen has a wealth of knowledge to share with founders.”
Rod Turner
CEO, Manhattan Street Capital
* [The above statement is provided by an advisor to the firm who is not currently nor has ever been a client of the firm. There has been no compensation paid of any type or kind in exchange for the statement. No material conflicts of interest exist arising from the relationship between the advisor and the client. The statements provided may not be indicative of all client experiences. There can be no performance guarantees or guarantees of success.]
Industry Leading Partners
CPVS™ gives you an extensive network of partners to guide you through a successful Reg A Offering . You will have access to the legal, compliance, marketing, and technology resources from industry leaders.
